Transcatheter Aortic Valve Implantation: Current and Evolving Indications

详细信息    查看全文

• 作者：Altayyeb Yousef ; MB ; MRCP(UK) ; Michael Froeschl ; MD ; MSc ; Benjamin Hibbert ; MD ; PhD ; Ian G. Burwash ; MD ; Marino Labinaz ; MD ; ^{mlabinaz@ottawaheart.ca" class="auth_mail" title="E-mail the corresponding author}
• 刊名：Canadian Journal of Cardiology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：32
• 期：2
• 页码：266-269
• 全文大小：273 K

文摘

Transcatheter Aortic Valve Implantation (TAVI) was initially developed to treat aortic stenosis in patients with high risk for surgical intervention. With great initial adoption of the technology and improvements in device design and procedural success TAVI is increasingly being performed in broader populations for diverse indications. This paper is a concise review of the evolving and expanding use of TAVI in the current era.